首页> 外文期刊>Trials >Efficacy of a new technique – INtubate-RECruit-SURfactant-Extubate – “IN-REC-SUR-E” – in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial
【24h】

Efficacy of a new technique – INtubate-RECruit-SURfactant-Extubate – “IN-REC-SUR-E” – in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial

机译:一项新技术的效果-插管-招募-表面活性剂-拔管-“ IN-REC-SUR-E”-在患有呼吸窘迫综合征的早产儿中:一项随机对照试验的研究方案

获取原文
获取外文期刊封面目录资料

摘要

Background Although beneficial in clinical practice, the INtubate-SURfactant-Extubate (IN-SUR-E) method is not successful in all preterm neonates with respiratory distress syndrome, with a reported failure rate ranging from 19 to 69?%. One of the possible mechanisms responsible for the unsuccessful IN-SUR-E method, requiring subsequent re-intubation and mechanical ventilation, is the inability of the preterm lung to achieve and maintain an “optimal” functional residual capacity. The importance of lung recruitment before surfactant administration has been demonstrated in animal studies showing that recruitment leads to a more homogeneous surfactant distribution within the lungs. Therefore, the aim of this study is to compare the application of a recruitment maneuver using the high-frequency oscillatory ventilation (HFOV) modality just before the surfactant administration followed by rapid extubation (INtubate-RECruit-SURfactant-Extubate: IN-REC-SUR-E) with IN-SUR-E alone in spontaneously breathing preterm infants requiring nasal continuous positive airway pressure (nCPAP) as initial respiratory support and reaching pre-defined CPAP failure criteria. Methods/design In this study, 206 spontaneously breathing infants born at 24+0–27+6 weeks’ gestation and failing nCPAP during the first 24?h of life, will be randomized to receive an HFOV recruitment maneuver (IN-REC-SUR-E) or no recruitment maneuver (IN-SUR-E) just prior to surfactant administration followed by prompt extubation. The primary outcome is the need for mechanical ventilation within the first 3?days of life. Infants in both groups will be considered to have reached the primary outcome when they are not extubated within 30?min after surfactant administration or when they meet the nCPAP failure criteria after extubation. Discussion From all available data no definitive evidence exists about a positive effect of recruitment before surfactant instillation, but a rationale exists for testing the following hypothesis: a lung recruitment maneuver performed with a step-by-step Continuous Distending Pressure increase during High-Frequency Oscillatory Ventilation (and not with a sustained inflation) could have a positive effects in terms of improved surfactant distribution and consequent its major efficacy in preterm newborns with respiratory distress syndrome. This represents our challenge. Trial registration ClinicalTrials.gov identifier: NCT02482766 . Registered on 1 June 2015.
机译:背景技术尽管插管表面活性剂-拔管法(IN-SUR-E)在临床上是有益的,但并不是在所有患有呼吸窘迫综合征的早产儿中都成功,据报道失败率在19%至69%之间。导致IN-SUR-E方法失败(可能需要随后重新插管和机械通气)的可能机制之一是早产肺无法实现和维持“最佳”功能性残余容量。在动物研究中已经证明了在使用表面活性剂之前进行肺募集的重要性,这表明募集会导致肺内表面活性剂分布更加均匀。因此,本研究的目的是比较在表面活性剂给药后快速拔管之前使用高频振荡通气(HFOV)方式进行招募策略的应用(INtubate-RECruit-SURfactant-Extubate:IN-REC-SUR -E)单独使用IN-SUR-E的自发呼吸早产儿需要鼻持续气道正压通气(nCPAP)作为初始呼吸支持并达到预先定义的CPAP失败标准。方法/设计在本研究中,将有206名在出生后24小时内自然呼吸的婴儿在24 +0 –27 +6 出生,并且nCPAP失败在给予表面活性剂后立即拔管之前,应随机接受HFOV募集操作(IN-REC-SUR-E)或不接受募集操作(IN-SUR-E)。主要结果是在生命的前三天内需要进行机械通气。当在表面活性剂给药后30分钟内未拔管或在拔管后符合nCPAP失败标准时,两组婴儿均被视为已达到主要结局。讨论从所有可用数据中都没有确切的证据表明在滴注表面活性剂之前会产生积极的补充作用,但是存在测试以下假设的理由:在高频震荡过程中,逐步进行持续的分压增加进行肺部补充动作通气(而不是持续的通气)可以改善表面活性剂的分布,从而在呼吸窘迫综合征早产儿中发挥主要作用,因此具有积极作用。这代表了我们的挑战。试用注册ClinicalTrials.gov标识符:NCT02482766。 2015年6月1日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号